Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

21-Oct-17 - 19-Oct-18
Buy Ratio:32%

Down

# Net Buyers:99
# Net Sellers:208

Previous 52 Weeks

22-Oct-16 - 20-Oct-17
Buy Ratio:41%
# Net Buyers:136
# Net Sellers:196
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Mylan N.V.($18.48M)$1.81B  
Kite Pharma, Inc.--$745.30M  
Bausch Health Companies Inc.$2.19M$234.05M  
Seattle Genetics Inc /wa$247.36M$178.37M  
Intrexon Corp$135.35M$120.97M  
New Net Buyers
CompanyNet Buy AmountChange
Bausch Health Companies Inc.$2.19M$234.05M  
Portola Pharmaceuticals Inc$5.31M$102.11M  
Corcept Therapeutics Inc$1.76M$66.20M  
Esperion Therapeutics, Inc.$14.24M$63.51M  
Akorn Inc$40.80M$43.77M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Juno Therapeutics, Inc.($1.28B)($1.06B)  
Colucid Pharmaceuticals, Inc.--($715.81M)  
Loxo Oncology, Inc.($438.98M)($432.29M)  
Regeneron Pharmaceuticals Inc($434.02M)($398.50M)  
Lilly Eli & Co($420.85M)($228.51M)  
New Net Sellers
CompanyNet Buy AmountChange
Alexion Pharmaceuticals, Inc.($4.02M)($217.26M)  
Madrigal Pharmaceuticals, Inc.($139.35M)($139.49M)  
Steadymed Ltd.($69.27M)($79.17M)  
Acorda Therapeutics Inc($58.10M)($70.78M)  
Corium International, Inc.($37.88M)($48.99M)